NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Is Mirum’s BLOOM Fragile X Trial Expanding a Durable Neurology Strategy for Mirum Pharmaceuticals (MIRM)?

Mirum Pharmaceuticals recently reported that it has enrolled the first participant in its BLOOM Phase 2 clinical study of MRM-3379 for Fragile X syndrome, a serious inherited neurodevelopmental condition with no approved treatments. This milestone moves Mirum’s rare disease pipeline further into neurology, highlighting how the company is testing its approach beyond liver-focused indications. We’ll now examine how launching the BLOOM Phase 2 Fragile X program could influence Mirum’s...
NYSE:GAP
NYSE:GAPSpecialty Retail

Is Gap Still Attractive After Its 109.5% Three Year Surge?

If you are wondering whether Gap at around $26.85 is still a bargain or if the easy money has already been made, you are not alone. That is exactly what this breakdown is here to unpack. The stock has slipped about 2.5% over the last week, but that comes after a strong 17.7% jump over the past month, a 13.7% gain year to date, and an impressive 109.5% climb over three years that has reshaped how the market views its potential. Recent headlines have focused on Gap's ongoing brand refresh,...
NasdaqGM:MDB
NasdaqGM:MDBIT

Assessing MongoDB After Its 65.9% 2025 Surge and Rich Growth Multiple

If you are wondering whether MongoDB is still a smart buy at today’s price, you are not alone; this stock has become one of the most talked about names in software. After a sharp 24.4% jump over the last week, a 14.1% gain over the past month, and a 65.9% climb year to date, the market clearly sees something it likes, but those moves also raise questions about how much upside is left from here. Recent headlines have focused on MongoDB’s expanding role in modern application development and...
NYSE:SPR
NYSE:SPRAerospace & Defense

Is Spirit AeroSystems Attractive After Strong Multi Year Share Price Gains in 2025?

If you are wondering whether Spirit AeroSystems Holdings is a smart buy at today’s price, you are not alone. This breakdown will help you decide whether the current price tag makes sense. The stock is now trading around $39.50, with returns of 9.3% over the last week, 8.2% over the last month, and 17.8% year to date, building on a 19.9% gain over the past year and 50.0% over three years. Recent moves in the share price have been driven by shifting expectations around commercial aircraft...
NYSE:CPNG
NYSE:CPNGMultiline Retail

What Coupang (CPNG)'s Record User Data Breach Means For Shareholders

Coupang recently disclosed that a data breach beginning in June exposed personal details for about 33.7 million users, including names, contact information, addresses, and order histories, prompting investigations by South Korea’s Personal Information Protection Commission and law enforcement. The incident, reportedly the country’s largest data leak in over a decade, raises significant questions about Coupang’s data governance, potential regulatory penalties, and long-term customer...
NasdaqGS:OSBC
NasdaqGS:OSBCBanks

Raymond James’ Reaffirmed Confidence In Old Second’s Expansion Strategy Might Change The Case For Investing In OSBC

Earlier this week, Raymond James reaffirmed its Strong Buy rating on Old Second Bancorp after the bank presented at the Raymond James Small Cap Bank Summit, highlighting confidence in the Evergreen Bank deal, its powersports lending niche, and steady loan growth prospects. The firm also underlined Old Second’s interest in acquiring another small bank in the Chicago metropolitan area, signaling continued expansion ambitions that could reshape its regional footprint and business mix over...
NYSE:EAT
NYSE:EATHospitality

Does Brinker International Still Offer Value After Its 332.9% Surge?

If you have been wondering whether Brinker International is still a bargain or if most of the upside is already priced in, you are not alone. This article is going to dig into that value question head on. After a powerful multi year run that has pushed the stock up 332.9% over 3 years and 165.5% over 5 years, the shares have cooled slightly with a 6.4% drop over the last week following a strong 35.2% gain in the past month. Much of the recent move has been driven by renewed optimism around...
NYSE:PMT
NYSE:PMTMortgage REITs

Did PennyMac’s Big Earnings Beat Amid Long-Term Declines Just Shift PMT’s Investment Narrative?

PennyMac Mortgage Investment Trust recently reported past-quarter revenues of US$99.23 million, a 22.7% year-on-year increase that exceeded analyst estimates, alongside better-than-expected EPS and net interest income. This strong quarterly surprise stands in contrast to the trust’s multi-year declines in sales, earnings per share, and tangible book value per share, raising questions about how durable the improvement might be. Next, we’ll examine how this earnings beat, despite longer-term...
NasdaqGS:LOT
NasdaqGS:LOTAuto

Does Lotus’s Q3 2025 Revenue Drop But Narrower Loss Reshape The Bull Case For LOT?

In November 2025, Lotus Technology Inc. reported third-quarter 2025 results showing revenue of US$137.43 million and a net loss of US$65.42 million, alongside 4,612 vehicle deliveries over the first nine months of the year amid tariffs, destocking, and phased upgraded model launches. While revenue fell sharply year on year, the smaller loss per share suggests cost controls are starting to take effect even as delivery volumes remain pressured by external and operational headwinds. With...
NYSE:ENS
NYSE:ENSElectrical

Should EnerSys’ AI Data Center Tailwinds and Upgraded Outlook Require Action From EnerSys (ENS) Investors?

Recent commentary has highlighted EnerSys as a beneficiary of AI-driven data center buildouts, citing its industrial battery solutions, consistent earnings outperformance over 16 consecutive quarters, and an upgraded full-year sales and earnings outlook. Analyst recognition of EnerSys’ role in powering mission-critical digital infrastructure adds an extra layer of interest for investors watching the intersection of energy storage and AI growth. We will now examine how EnerSys’ AI data...
NasdaqGS:DVAX
NasdaqGS:DVAXBiotechs

Assessing Dynavax After Recent Vaccine Progress and a 140% Five Year Share Price Surge

If you are wondering whether Dynavax Technologies is quietly turning into a value opportunity or just another biotech rollercoaster, you are in the right place. The stock has slipped about 4% over the last week but is still up roughly 9.2% over the past month, even though it remains down around 15.0% year to date and 14.5% over the last year, after a strong 140.0% gain over five years. Recent attention has centered on Dynavax's expanding role in vaccine adjuvants and partnerships that aim to...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Is Nutanix At $47 A Share An Opportunity After Recent 33% Slide?

If you are wondering whether Nutanix at around $47 a share is a bargain in disguise or a value trap waiting to happen, this breakdown is for you. The stock has slid about 33.3% over the last month and is down 22.6% year to date, yet it is still sitting on gains of roughly 57.4% over 3 years and 59.6% over 5 years. That kind of whiplash in returns has coincided with shifting sentiment around high growth software names, as investors rotate between riskier cloud stories and more predictable...
NYSE:BROS
NYSE:BROSHospitality

Is Dutch Bros Share Price Justified After Strong Multi Year Run In 2025?

If you are wondering whether Dutch Bros at around $61 a share is a caffeine fueled bargain or just pricey buzz, this article is for you. We are going to unpack what the current market price really implies about its future. The stock has quietly kept the momentum going, up about 5% over the last week, 12.3% over the past month, and roughly 12.9% over the last year, compounding into an 87.2% gain over three years. Behind those moves, Dutch Bros has been steadily expanding its store footprint...
NasdaqGM:CVAC
NasdaqGM:CVACBiotechs

Reassessing CureVac (NasdaqGM:CVAC) Valuation After Its Removal From the NASDAQ Biotechnology Index

CureVac (NasdaqGM:CVAC) has just been dropped from the NASDAQ Biotechnology Index, a mechanical change that can still matter for investors as index tracking funds trim positions and liquidity dynamics start to shift. See our latest analysis for CureVac. That index removal lands after a busy stretch for CureVac, including new board appointments and mixed earnings. It also comes at a time when the share price has climbed sharply year to date, although longer term total shareholder returns still...
NYSE:GSL
NYSE:GSLShipping

Evaluating Global Ship Lease (NYSE:GSL) After $90m ECO Containership Deal and Fleet Expansion to 71 Vessels

Global Ship Lease (NYSE:GSL) is leaning into its fleet renewal strategy by agreeing to buy three Korean built 8,600 TEU containerships with ECO upgrades and long term charters attached for $90 million. See our latest analysis for Global Ship Lease. That strategy is landing against a strong backdrop, with the share price up 14.4 percent over the past month and delivering a 73.6 percent total shareholder return over the last year. This suggests momentum is building as earnings and fleet moves...
NasdaqGS:ABSI
NasdaqGS:ABSIBiotechs

Assessing Absci (ABSI) Valuation After First Volunteers Dosed in ABS-201 HeadLINE Trial

Absci (ABSI) just crossed an important milestone by dosing the first healthy volunteers in its Phase 1/2a HeadLINE trial for ABS-201, an AI designed antibody targeting androgenetic alopecia and, later, endometriosis. See our latest analysis for Absci. The ABS-201 milestone lands after a volatile stretch, with the share price up 8.6 percent over one day and 6.5 percent over seven days, yet still showing a negative 30 day share price return while the 1 year total shareholder return remains...
NasdaqGS:SAIC
NasdaqGS:SAICProfessional Services

Reassessing Science Applications International After a 22% Slide in 2025

If you are wondering whether Science Applications International is quietly turning into a value opportunity after a rough stretch in the market, you are not alone. This is exactly what we are going to unpack. The stock now trades around $87.53, up 2.1% over the last week but still down 4.2% over 30 days and 22.0% year to date, reflecting a market that has cooled on the name after a longer 1 year slide of 28.4%. In recent months, investor attention has been shaped more by shifting sentiment...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

High Growth US Tech Stocks To Watch In December 2025

As the Dow Jones and S&P 500 approach record highs, buoyed by expectations of a potential Federal Reserve rate cut, the U.S. tech sector remains a focal point for investors navigating an evolving economic landscape marked by mixed employment data and fluctuating Treasury yields. In such a dynamic environment, identifying high-growth tech stocks involves assessing factors like innovation potential, market positioning, and adaptability to macroeconomic shifts that can influence performance in...
NYSE:TLYS
NYSE:TLYSSpecialty Retail

3 Promising Penny Stocks With Market Caps Below $200M

As the Dow Jones and S&P 500 approach record highs, investors are keeping a close eye on market movements and potential interest rate cuts by the Federal Reserve. Investing in penny stocks—though a somewhat outdated term—remains relevant as these stocks often represent smaller or newer companies that can offer unique growth opportunities. By focusing on those with strong financials, investors may uncover hidden gems poised for long-term success amidst current market conditions.
NYSE:BSM
NYSE:BSMOil and Gas

How Black Stone’s Long-Term Caturus Drilling Pact in Haynesville and Shelby Trough At Black Stone Minerals (BSM) Has Changed Its Investment Story

In December 2025, Black Stone Minerals, L.P. announced it had entered into a multi-year development agreement with an affiliate of Caturus Energy, covering 220,000 gross acres in the Shelby Trough and Haynesville Expansion to support growing Gulf Coast natural gas demand. The deal outlines a structured ramp-up from pilot wells in the first two years to about 12 gross wells annually by year six, potentially unlocking more value from Black Stone’s roughly 40,000 undeveloped net acres in the...